In the promising field of cellular therapy for retinal degenerative diseases, a new biomaterial is proposed as a scaffold to grow and surgically introduce a monolayer of retinal pigment epithelial cells into the subretinal space, keeping the orientation of the cells for a proper functional integration of the transplant. The use of induced pluripotent stem cells as the starting material for retinal pigment epithelial cells is intended to advance toward a personalized medicine approach.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1089/ten.TEA.2019.0007 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!